Trials / Conditions / Thrombotic Thrombocytopenic Purpura, Acquired

Thrombotic Thrombocytopenic Purpura, Acquired

5 registered clinical trials studyying Thrombotic Thrombocytopenic Purpura, Acquired — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura NCT07513948	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	—
Recruiting	Association of TNFAIP3 With Immune-mediated TTP NCT06928233	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	N/A
Unknown	A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian E NCT05262881	Catholic University of the Sacred Heart	—
Unknown	Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP NCT05135442	Peking Union Medical College Hospital	Phase 4
Terminated	Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP NCT04720261	University Hospital, Rouen	Phase 2